课题基金 / 基金详情

Role of mechanosensation in retinal function and dysfunction

Role of mechanosensation in retinal function and dysfunction
机械感觉在视网膜功能和功能障碍中的作用
批准号:
8437597
负责人:
DAVID KRIZAJ
金额:
$37.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-12-01 至 2016-11-30

项目摘要

项目成果

DAVID KRIZAJ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Glaucoma is complex of devastating blinding diseases that together represent the primary cause of irreversible blindness in the U.S. There is substantial evidence that pathological mechanical stimulation mediated by an increase in intraocular pressure (IOP) plays a causal role in the etiology of glaucoma. The present proposal is to characterize the molecular mechanisms which might underlie the cellular response in this disease but could also play a key function in other diseases that involve mechanical stress in the retina, such as diabetic retinopathy, ischemia and macular edema. We found that a mechanosensitive cation channel, TRPV4, is selectively localized to retinal ganglion cells (RGCs) and in Muller glial cells. Because these are the two cell types that are specifically targeted in glaucoma, we hypothesize that mechanosensitive channels mediate the effects of pathological increases in IOP. The central focus of the proposal is to characterize this transduction mechanism in RGCs by combining biophysical, cellular and translational approaches. Studies proposed in Aim 1 will establish the molecular mechanism of mechanosensitive channel activation and desensitization, their role in calcium transport, cellular physiology and RGC survival. We will test conditions that mimic RGC injury in "low-tension" pathologies and test a number of models under which mechanosensitive channels might contribute to excitotoxic RGC injury. The proposed studies will also capitalize on preliminary work which shows remarkable effectiveness of non toxic small molecule antagonists in blocking pressure-stimulated loss of RGCs in vitro and in vivo glaucoma models. Aim 2 of the proposed research builds on the characterization of pressure-sensitive channels in Aim 1 to study how these mechanisms regulate the swelling response of RGCs and retinal astroglia. Although cells typically swell in response to normal light-evoked neuronal activity, swelling is exacerbated in pathological conditions such as ischemia and diabetes, and can be highly neurotoxic. The proposed studies will explore the molecular complexes that involve swelling-activated calcium channels, water channels, calcium waves and regulatory volume decrease mechanisms. Thus, the goal of proposed research is to establish an intuitive conceptual and experimental framework that helps unify our understanding of retinal IOP transduction, cell swelling, and volume sensing and calcium homeostasis in retinal cells. By doing so, it will help predict the effects of mechanical forces that act through direct hydrostatic compression of cellular membranes as well as determine molecular mechanisms that are activated by tensile stretching, pulling and swelling. We will then test these predictions using mouse models of inducible and chronic glaucoma. This may help to refine our understanding of mechanical injury in vision disorders such as glaucoma, diabetic retinopathy and ischemia and contribute to developing effective neuroprotective treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and Molecular Mechanisms that Contribute to Pressure-Induced Retinal Inflammation and Pathology
  • 批准号:
    10656446
  • 项目类别:
  • 资助金额:
    $38.35万
  • 财政年份:
    2021
  • 负责人:
    DAVID KRIZAJ
  • 依托单位:
Cellular and Molecular Mechanisms that Contribute to Pressure-Induced Retinal Inflammation and Pathology
  • 批准号:
    10219761
  • 项目类别:
  • 资助金额:
    $39.66万
  • 财政年份:
    2021
  • 负责人:
    DAVID KRIZAJ
  • 依托单位:
Cellular and Molecular Mechanisms that Contribute to Pressure-Induced Retinal Inflammation and Pathology
  • 批准号:
    10430079
  • 项目类别:
  • 资助金额:
    $37.2万
  • 财政年份:
    2021
  • 负责人:
    DAVID KRIZAJ
  • 依托单位:
Molecular mechanisms of mechanotransduction in the aqueous outflow pathway
  • 批准号:
    9915926
  • 项目类别:
  • 资助金额:
    $38.13万
  • 财政年份:
    2017
  • 负责人:
    DAVID KRIZAJ
  • 依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
  • 批准号:
    31760279
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2017
  • 负责人:
    丁银秀
  • 依托单位: